Skip to content


Orion develops, manufactures and markets human and veterinary pharmaceuticals and active pharmaceutical ingredients. We invest in research and development to bring new treatment options for patients.

Orion's products are sold in over a hundred countries. Our product portfolio includes proprietary drugs developed by Orion itself, generic drugs, self-care products - such as non-prescription medicines.

Orion Pharma Australia became operational in 2022 with a portfolio of proprietary and generic medicines and consumer health products for the treatment of menopause, arthritis, respiratory disease, constipation, breast cancer, Parkinson’s disease and intensive care sedation.